Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 111, Issue 5, Pages 1280-1291Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.xphs.2022.02.009
Keywords
Industry practice; Biotechnology products; Polysorbate; Survey report; Surfactant(s); Stability; Protein(s)
Ask authors/readers for more resources
This study report presents the industry practices, stability, and regulatory aspects of polysorbates in biopharmaceutical products, comparing the findings with available scientific literature. The upcoming second part of the report will focus on exploring the degradation pathways of polysorbates and developing effective control strategies.
Polysorbates (PS) are widely used as a stabilizer in biopharmaceutical products. Industry practices on various aspects of PS are presented in this part 1 survey report based on a confidential survey and following discussions by 16 globally acting major biotechnology companies. The current practice and use of PS during manufacture across their global manufacturing sites are covered in addition to aspects like current understanding of the (in)stability of PS, the routine QC testing and control of PS, and selected regulatory aspects of PS. The results of the survey and extensive cross-company discussions are put into relation with currently available scientific literature. Part 2 of the survey report (upcoming) will focus on understanding, monitoring, prediction, and mitigation of PS degradation pathways to develop an effective control strategy.(c) 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available